Gliatech Weighing Adcon Sale, Bankruptcy Filing; DoJ Makes Example Of Firm
This article was originally published in The Gray Sheet
Executive Summary
Gliatech is considering the sale of its flagship Adcon anti-adhesion technology and filing for bankruptcy following a recent settlement with the Department of Justice due to failure to supply required information to FDA